부산대학교 도서관

PATCH TESTING WITH MDBGN/DBDCB Various substances, concentrations, and patch-test systems have been used for the diagnosis of contact allergy to MDBGN/DBDCB. Considering the experience of the recent MDBGN/DBDCB contact allergy epidemic, Skin Sens. 1A would be the most relevant. For medicinal products and medical devices, MDBGN/DBDCB is implicitly permitted, provided that the products meet the general standards on risk vs benefit (Table 1). We fear that an increasing number of various products containing MDBGN/DBDCB as an in-can preservative (PT6) will be placed in the market in Europe, and that MDBGN/DBDCB will be undisclosed if not classified (see above). [Extracted from the article]